282 related articles for article (PubMed ID: 24168060)
1. Interleukin-6 induces malignant transformation of rat mesenchymal stem cells in association with enhanced signaling of signal transducer and activator of transcription 3.
Cui X; Liu J; Bai L; Tian J; Zhu J
Cancer Sci; 2014 Jan; 105(1):64-71. PubMed ID: 24168060
[TBL] [Abstract][Full Text] [Related]
2. IL22 furthers malignant transformation of rat mesenchymal stem cells, possibly in association with IL22RA1/STAT3 signaling.
Cui X; Jing X; Yi Q; Xiang Z; Tian J; Tan B; Zhu J
Oncol Rep; 2019 Apr; 41(4):2148-2158. PubMed ID: 30816520
[TBL] [Abstract][Full Text] [Related]
3. C6 glioma-conditioned medium induces malignant transformation of mesenchymal stem cells: Possible role of S100B/RAGE pathway.
Tan B; Shen L; Yang K; Huang D; Li X; Li Y; Zhao L; Chen J; Yi Q; Xu H; Tian J; Zhu J
Biochem Biophys Res Commun; 2018 Jan; 495(1):78-85. PubMed ID: 29050939
[TBL] [Abstract][Full Text] [Related]
4. Correlation and malignant transformation of MSCs with the overexpression of SIL-R/GP130 under the tumor microenvironment.
Hou Z; Cui N; Cui Y; Xing H; Liu W
Med Oncol; 2015 Jan; 32(1):328. PubMed ID: 25433944
[TBL] [Abstract][Full Text] [Related]
5. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM
Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018
[TBL] [Abstract][Full Text] [Related]
6. Phospholipid scramblase 1 acts through the IL-6/JAK/STAT3 pathway to promote the malignant progression of glioma.
Zhou S; Xu J; Zhu Y
Arch Biochem Biophys; 2024 Jun; 756():110002. PubMed ID: 38636689
[TBL] [Abstract][Full Text] [Related]
7. Role of MMP-2 in the regulation of IL-6/Stat3 survival signaling via interaction with α5β1 integrin in glioma.
Kesanakurti D; Chetty C; Dinh DH; Gujrati M; Rao JS
Oncogene; 2013 Jan; 32(3):327-40. PubMed ID: 22349830
[TBL] [Abstract][Full Text] [Related]
8. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
9. Dobesilate inhibits the activation of signal transducer and activator of transcription 3, and the expression of cyclin D1 and bcl-XL in glioma cells.
Cuevas P; Díaz-González D; Sánchez I; Lozano RM; Giménez-Gallego G; Dujovny M
Neurol Res; 2006 Mar; 28(2):127-30. PubMed ID: 16551428
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow-derived myofibroblasts promote colon tumorigenesis through the IL-6/JAK2/STAT3 pathway.
Zhu L; Cheng X; Ding Y; Shi J; Jin H; Wang H; Wu Y; Ye J; Lu Y; Wang TC; Yang CS; Tu SP
Cancer Lett; 2014 Feb; 343(1):80-9. PubMed ID: 24145153
[TBL] [Abstract][Full Text] [Related]
11. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.
Zhang HY; Zhang Q; Zhang X; Yu C; Huo X; Cheng E; Wang DH; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G454-60. PubMed ID: 21148399
[TBL] [Abstract][Full Text] [Related]
12. [Gastric cancer-derived mesenchymal stem cells regulate the M2 polarization of macrophages within gastric cancer microenvironment via JAK2/STAT3 signaling pathway].
Li W; Zhao SL; Zheng P; Shi PQ; Zhou Y; Zhang T; Huo J; Yang J
Zhonghua Zhong Liu Za Zhi; 2022 Jul; 44(7):728-736. PubMed ID: 35880339
[No Abstract] [Full Text] [Related]
13. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling.
Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L
Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257
[TBL] [Abstract][Full Text] [Related]
14. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
15. Rat bone marrow mesenchymal stem cells undergo malignant transformation via indirect co-cultured with tumour cells.
Liu J; Zhang Y; Bai L; Cui X; Zhu J
Cell Biochem Funct; 2012 Dec; 30(8):650-6. PubMed ID: 22763674
[TBL] [Abstract][Full Text] [Related]
16. Activation of a pro-survival pathway IL-6/JAK2/STAT3 contributes to glial fibrillary acidic protein induction during the cholera toxin-induced differentiation of C6 malignant glioma cells.
Shu M; Zhou Y; Zhu W; Wu S; Zheng X; Yan G
Mol Oncol; 2011 Jun; 5(3):265-72. PubMed ID: 21470923
[TBL] [Abstract][Full Text] [Related]
17. Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism.
Poynter JA; Herrmann JL; Manukyan MC; Wang Y; Abarbanell AM; Weil BR; Brewster BD; Meldrum DR
J Am Coll Surg; 2011 Aug; 213(2):253-60. PubMed ID: 21546276
[TBL] [Abstract][Full Text] [Related]
18. Activation of signal transducers and activators of transcription 3 and focal adhesion kinase by stromal cell-derived factor 1 is required for migration of human mesenchymal stem cells in response to tumor cell-conditioned medium.
Gao H; Priebe W; Glod J; Banerjee D
Stem Cells; 2009 Apr; 27(4):857-65. PubMed ID: 19350687
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway.
Liu WH; Liu JJ; Wu J; Zhang LL; Liu F; Yin L; Zhang MM; Yu B
PLoS One; 2013; 8(1):e55487. PubMed ID: 23383203
[TBL] [Abstract][Full Text] [Related]
20. Differential interleukin-6/Stat3 signaling as a function of cellular context mediates Ras-induced transformation.
Leslie K; Gao SP; Berishaj M; Podsypanina K; Ho H; Ivashkiv L; Bromberg J
Breast Cancer Res; 2010; 12(5):R80. PubMed ID: 20929542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
